Kura Oncology, Inc. - Common Stock (NQ:KURA)

10.41 +0.02 (+0.24%)

Streaming Delayed Price Updated: 2:58 PM EDT, Jul 27, 2026 Add to My Watchlist

Price and Volume

Volume	514,152
Open	10.72
Bid (Size)	10.40 (400)
Ask (Size)	10.43 (400)
Prev. Close	10.39
Today's Range	10.37 - 10.77
52wk Range	5.450 - 12.49
Shares Outstanding	68,438,576
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kura Oncology Reports 50% Response Rate in RCC Combination Study ↗

Today 12:01 EDT

Kura Oncology (NASDAQ:KURA) presented updated results from its Phase 1 FIT-001 trial evaluating darlifarnib in combination with cabozantinib for locally advanced or metastatic renal cell carcinoma...

Via MarketBeat

Kura Oncology Reports Q1 2026 Results: Full Earnings Call Transcript ↗

July 02, 2026

Kura Oncology (NASDAQ:KURA) released first-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For...

Via Benzinga

Performance

YTD	+0.8%	+0.8%
1 Month	-4.4%	-4.4%
3 Month	+14.8%	+14.8%
6 Month	+21.5%	+21.5%
1 Year	+68.1%	+68.1%

More News

Kura Oncology Q1 Earnings Call Highlights ↗

May 12, 2026

Via MarketBeat

Kura Oncology (NASDAQ:KURA) Slips After Q1 Earnings Miss ↗

May 12, 2026

Via Chartmill

Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

May 12, 2026

From Kura Oncology, Inc.

Via GlobeNewswire

KURA ONCOLOGY INC (NASDAQ:KURA) Posts Q4 Revenue Beat but EPS Miss, Stock Falls in Pre-Market ↗

March 05, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement ↗

October 24, 2025

Via Stocktwits

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

April 17, 2026

From Kura Oncology, Inc.

Via GlobeNewswire

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

January 11, 2026

From Kura Oncology, Inc.

Via GlobeNewswire

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally

December 22, 2025

Via MarketMinute

Kura Scores A Big Win As FDA Approves Its New Leukemia Pill ↗

November 14, 2025

Via Benzinga

Kura Oncology Stock Ignites Retail Frenzy After FDA Clears First Daily Pill For Relapsed Leukemia Patients ↗

November 14, 2025

Via Stocktwits

Tech's AI Surge Meets Pharma's Resilient Recovery: A Tale of Two Markets in Late 2025

November 05, 2025

Via MarketMinute

Kura Oncology (NASDAQ:KURA) Reports Q3 2025 Revenue Miss But Narrower-Than-Expected Loss ↗

November 04, 2025

Via Chartmill

Kura Oncology Scores $30 Million Boost As New Leukemia Drug Enters Major Trial ↗

October 24, 2025

Via Benzinga

Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data

October 03, 2025

Via MarketMinute

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 09, 2025

Via Benzinga

Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth ↗

September 04, 2025

Via Benzinga

This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

September 04, 2025

Via Benzinga

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday ↗

August 15, 2025

Via Benzinga

Kura (KURA) Revenue Drops 61% ↗

August 07, 2025

Via The Motley Fool

Frequently Asked Questions

Is Kura Oncology, Inc. - Common Stock publicly traded?

Yes, Kura Oncology, Inc. - Common Stock is publicly traded.

What exchange does Kura Oncology, Inc. - Common Stock trade on?

Kura Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kura Oncology, Inc. - Common Stock?

The ticker symbol for Kura Oncology, Inc. - Common Stock is KURA on the Nasdaq Stock Market

What is the current price of Kura Oncology, Inc. - Common Stock?

The current price of Kura Oncology, Inc. - Common Stock is 10.41

When was Kura Oncology, Inc. - Common Stock last traded?

The last trade of Kura Oncology, Inc. - Common Stock was at 07/27/26 02:58 PM ET

What is the market capitalization of Kura Oncology, Inc. - Common Stock?

The market capitalization of Kura Oncology, Inc. - Common Stock is 712.79M

How many shares of Kura Oncology, Inc. - Common Stock are outstanding?

Kura Oncology, Inc. - Common Stock has 713M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.